Case Study
Global market access assessment for a companion diagnostic test: new challenges in reimbursement
Objectives: To outline the expected reimbursement process for novel companion diagnostics in each target market to understand how tumor associated antigen and gene signature tests will be evaluated for reimbursement in Europe, US and Japan
Research
- Performed comprehensive secondary research to guide the development of background materials
- Iterative development of discussion guides and discussion support materials based on client objectives
- Translation of discussion materials for non-English speaking markets
Analyze
- Recruited companion diagnostics experts and reimbursement stakeholders across markets (e.g. payers/clinical experts, lab directors, physicians)
- Identified factors which may impact the reimbursement decision-making for the tests (e.g. challenges, value drivers, perceived unmet need)
- Organized and executed stakeholder discussions with the respondents across markets
Communicate
- Analysis of findings, including clarification of information gaps and/or inconsistencies, additional secondary research to confirm findings
- Definition of reimbursement pathway for each market and development of strategic recommendations for optimal market access
Back to Case Studies
Contact Us